John Kasckow

5.1k total citations
105 papers, 3.8k citations indexed

About

John Kasckow is a scholar working on Psychiatry and Mental health, Social Psychology and Clinical Psychology. According to data from OpenAlex, John Kasckow has authored 105 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Psychiatry and Mental health, 29 papers in Social Psychology and 28 papers in Clinical Psychology. Recurrent topics in John Kasckow's work include Schizophrenia research and treatment (34 papers), Stress Responses and Cortisol (24 papers) and Treatment of Major Depression (24 papers). John Kasckow is often cited by papers focused on Schizophrenia research and treatment (34 papers), Stress Responses and Cortisol (24 papers) and Treatment of Major Depression (24 papers). John Kasckow collaborates with scholars based in United States, Canada and Australia. John Kasckow's co-authors include Thomas D. Geracioti, Sidney Zisook, Dewleen G. Baker, Kelly Hill, Nosa N. Ekhator, Scott A. West, Ann Bruce, Somaia Mohamed, Charles B. Nemeroff and Lawrence B. Inderbitzin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal of Psychiatry and Annals of Neurology.

In The Last Decade

John Kasckow

105 papers receiving 3.6k citations

Peers

Countries citing papers authored by John Kasckow

Since Specialization

Citations

This map shows the geographic impact of John Kasckow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Kasckow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Kasckow more than expected).

Fields of papers citing papers by John Kasckow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Kasckow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Kasckow. The network helps show where John Kasckow may publish in the future.

Co-authorship network of co-authors of John Kasckow

This figure shows the co-authorship network connecting the top 25 collaborators of John Kasckow. A scholar is included among the top collaborators of John Kasckow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Kasckow. John Kasckow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of next-step antidepressant treatment on suicidal ideation: findings from the VAST-D trial 2023 ·Psychological Medicine ·Sidney Zisook, Christine Moutier, A. John Rush, Gary R. Johnson, Ilanit Tal, Peijun Chen, Lori L. Davis, Paul B. Hicks, James A. Wilcox, Beata Planeta, (unknown), Alexandra Scrymgeour, John Kasckow, Somaia Mohamed	2
2	The role of late life depressive symptoms on the trajectories of insomnia symptoms during antidepressant treatment 2017 ·Journal of Psychiatric Research ·Marie Anne Gebara, John Kasckow, Stephen F. Smagula, Elizabeth A. DiNapoli, Jordan F. Karp, Eric J. Lenze, Benoit H. Mulsant, Charles F. Reynolds	7
3	Sedative hypnotic use among veterans with a newly reported mental health disorder 2016 ·International Psychogeriatrics ·Elizabeth A. DiNapoli, Adam D. Bramoweth, (unknown), John Kasckow	6
4	Using telehealth to augment an intensive case monitoring program in veterans with schizophrenia and suicidal ideation: A pilot trial 2016 ·Psychiatry Research ·John Kasckow, Susan Zickmund, John A. Gurklis, James F. Luther, Lauren Fox, Melissa Taylor, (unknown), Gretchen L. Haas	24
5	Does Age Moderate the Relationship Between Depressive Symptoms and Suicidal Ideation in Middle-Aged and Older Patients with Schizophrenia and Subthreshold Depression? 2013 ·American Journal of Geriatric Psychiatry ·John Kasckow, Shahrokh Golshan, Sidney Zisook	9
6	Racial Preferences for Participation in a Depression Prevention Trial Involving Problem-Solving Therapy 2010 ·Psychiatric Services ·John Kasckow, Charlotte Brown, Jennifer Q. Morse, Irina Karpov, Salem Bensasi, Stephen B. Thomas, (unknown), Charles F. Reynolds	5
7	Treatment of subsyndromal depressive symptoms in middle‐aged and older adults with schizophrenia: effect on functioning 2009 ·International Journal of Geriatric Psychiatry ·John Kasckow, Nicole M. Lanouette, Thomas L. Patterson, Ian E. Fellows, Shahrokh Golshan, Ellen Solorzano, Sidney Zisook	18
8	Effects of trauma-related audiovisual stimulation on cerebrospinal fluid norepinephrine and corticotropin-releasing hormone concentrations in post-traumatic stress disorder 2008 ·Psychoneuroendocrinology ·Thomas D. Geracioti, Dewleen G. Baker, John Kasckow, Jeffrey R. Strawn, J. JEFFREY MULCHAHEY, Boris A. Dashevsky, Paul S. Horn, Nosakhare N. Ekhator	80
9	Effects of estradiol on regulation of corticotropin-releasing factor gene and interleukin-6 production via estrogen receptor type β in hypothalamic 4B cells 2007 ·Peptides ·(unknown), Kazunori Kageyama, (unknown), John Kasckow, Toshihiro Suda	27
10	Depressive symptom patterns in patients with chronic schizophrenia and subsyndromal depression 2006 ·Schizophrenia Research ·Sidney Zisook, Maren Nyer, John Kasckow, (unknown), David H. Lehman, Lori P. Montross	48
11	Childhood Trauma and Personality Disorder: Positive Correlation With Adult CSF Corticotropin-Releasing Factor Concentrations 2005 ·American Journal of Psychiatry ·Royce Lee, Thomas D. Geracioti, John Kasckow, Emil F. Coccaro	57
12	Predominant role by CaM kinase in NPY Y1 receptor signaling: Involvement of CREB and Ambikaipakan 2002 ·Peptides ·Sulaiman Sheriff, (unknown), William T. Chance, John Kasckow, Ambikaipakan Balasubramaniam	20
13	A Double-Blind, Randomized, Prospective Evaluation of the Efficacy and Safety of Risperidone Versus Haloperidol in the Treatment of Schizoaffective Disorder 2001 ·Journal of Clinical Psychopharmacology ·P G Janicak, Paul E. Keck, John M. Davis, John Kasckow, Karen C. Tugrul, Sheila M. Dowd, Jane Strong, Rajiv P. Sharma, Stephen M. Strakowski	32
14	Health-related quality of well-being in chronically hospitalized patients with schizophrenia: comparison with matched outpatients 2001 ·Psychiatry Research ·John Kasckow, Elizabeth W. Twamley, (unknown), Brendan T. Carroll, (unknown), Stephen M. Strakowski, Thomas L. Patterson, Dilip V. Jeste	74
15	Serotonin-selective reuptake inhibitors in the treatment of geriatric depression and related disorders 1999 ·The International Journal of Neuropsychopharmacology ·(unknown), (unknown), (unknown), John Kasckow	5
16	Regulation of corticotropin-releasing factor messenger RNA by nicotine in an immortalized amygdalar cell line 1999 ·Life Sciences ·John Kasckow, Ajit Regmi, (unknown), (unknown), (unknown)	11
17	Changes in brain corticotropin-releasing factor messenger RNA expression in aged Fischer 344 rats 1999 ·Brain Research ·John Kasckow, Ajit Regmi, (unknown), Paul M. Plotsky, Richard L. Hauger	19
18	Substance use: a powerful predictor of relapse in schizophrenia 1996 ·Schizophrenia Research ·(unknown), John Kasckow, (unknown), Lawrence B. Inderbitzin	203
19	The BE (2)-M17 neuroblastoma cell line synthesizes and secretes corticotropin-releasing factor 1994 ·Brain Research ·John Kasckow, David G. Parkes, Michael J. Owens, (unknown), Jin‐Hee Han, Charles B. Nemeroff, Wylie Vale	12
20	Interleukin‐1α induces corticotropin‐releasing factor secretion and synthesis from NPLC‐KC cells through various second messenger pathways 1994 ·Synapse ·John Kasckow, (unknown), Jin‐Hee Han, Michael J. Owens, (unknown), (unknown), Charles B. Nemeroff	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact